Xenetic Biosciences (XBIO) Intangibles (2014 - 2020)
Xenetic Biosciences' (XBIO) quarterly Intangibles came in at $9.2 million in Q2 2020, little changed YoY from $9.2 million in Q3 2019, and little changed on a QoQ basis from $9.2 million in Q1 2020.
Xenetic Biosciences (XBIO) Intangibles (2014 - 2020) Analysis & Trends
Xenetic Biosciences (XBIO) has 7 years of Intangibles data on file, last reported at $9.2 million in Q2 2020.
- Quarterly Intangibles changed 0.0% year-over-year to $9.2 million in Q2 2020, while the trailing twelve-month figure through Jun 2020 was $9.2 million (changed 0.0% YoY) and the FY2019 annual result came in at $9.2 million, changed 0.0% from the prior year.
- Intangibles was little changed at $9.2 million in Q2 2020, from $9.2 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $9.2 million in Q1 2016 to a low of $9.2 million in Q1 2016.
- A 5-year average of $9.2 million and a median of $9.2 million in 2016 frame the typical range for Intangibles.
- The widest YoY moves for Intangibles: up 0.0% in 2016, down 0.6% in 2016.
- Tracing XBIO's Intangibles over 5 years: stood at $9.2 million in 2016, then changed by 0.0% to $9.2 million in 2017, then changed by 0.0% to $9.2 million in 2018, then changed by 0.0% to $9.2 million in 2019, then changed by 0.0% to $9.2 million in 2020.
- The last three Intangibles figures came in at $9.2 million (Q2 2020), $9.2 million (Q1 2020), and $9.2 million (Q4 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Xenetic Biosciences | 8.01 Mn | 1.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 9.24 Mn |
| Mar 31, 2020 | 9.24 Mn |
| Dec 31, 2019 | 9.24 Mn |
| Sep 30, 2019 | 9.24 Mn |
| Jun 30, 2019 | 9.24 Mn |
| Mar 31, 2019 | 9.24 Mn |
| Dec 31, 2018 | 9.24 Mn |
| Sep 30, 2018 | 9.24 Mn |
| Jun 30, 2018 | 9.24 Mn |
| Mar 31, 2018 | 9.24 Mn |
| Dec 31, 2017 | 9.24 Mn |
| Sep 30, 2017 | 9.24 Mn |
| Jun 30, 2017 | 9.24 Mn |
| Mar 31, 2017 | 9.24 Mn |
| Dec 31, 2016 | 9.24 Mn |
| Sep 30, 2016 | 9.24 Mn |
| Jun 30, 2016 | 9.24 Mn |
| Mar 31, 2016 | 9.24 Mn |
| Dec 31, 2015 | 9.24 Mn |
| Sep 30, 2015 | 9.24 Mn |